Advanced search
1 file | 219.89 KB

Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin

(2009) Eye. 23(12). p.2260-2262
Author
Organization
Abstract
OBJECTIVE: To report a newly recognized adverse effect of oral moxifloxacin. DESIGN: Observational case reports. PARTICIPANTS: Five patients who used oral moxifloxacin therapy. MAIN OUTCOME MEASURES: In five patients, a uveitis-like episode followed oral moxifloxacin therapy, afterwards they experienced photophobia. At slitlamp investigation, the patients showed almost complete iris transillumination, not restricted to one sector, and persistent mydriasis of the pupil, with no reaction to light and no near reflex. Follow-up of 3 years in one of the patients showed no change of symptoms. Only in one patient, with a history of anterior uveitis, an anterior chamber tap was positive for herpes simplex genome. Only after the use of moxifloxacin did she experience continuous photophobia. CONCLUSIONS: Iris transillumination and sphincter paralysis is a newly recognized adverse effect of oral moxifloxacin therapy.

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 219.89 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Wefers Bettink-Remeijer, Marijke, Katrien Brouwers, Luc Van Langenhove, Peter De Waard, Tom Missotten, José Martinez Ciriano, and Elisabeth Van Aken. 2009. “Uveitis-like Syndrome and Iris Transillumination After the Use of Oral Moxifloxacin.” Eye 23 (12): 2260–2262.
APA
Wefers Bettink-Remeijer, M., Brouwers, K., Van Langenhove, L., De Waard, P., Missotten, T., Martinez Ciriano, J., & Van Aken, E. (2009). Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. Eye, 23(12), 2260–2262.
Vancouver
1.
Wefers Bettink-Remeijer M, Brouwers K, Van Langenhove L, De Waard P, Missotten T, Martinez Ciriano J, et al. Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. Eye. 2009;23(12):2260–2.
MLA
Wefers Bettink-Remeijer, Marijke, Katrien Brouwers, Luc Van Langenhove, et al. “Uveitis-like Syndrome and Iris Transillumination After the Use of Oral Moxifloxacin.” Eye 23.12 (2009): 2260–2262. Print.
@article{846221,
  abstract     = {OBJECTIVE: To report a newly recognized adverse effect of oral moxifloxacin. DESIGN: Observational case reports. PARTICIPANTS: Five patients who used oral moxifloxacin therapy. MAIN OUTCOME MEASURES: In five patients, a uveitis-like episode followed oral moxifloxacin therapy, afterwards they experienced photophobia. At slitlamp investigation, the patients showed almost complete iris transillumination, not restricted to one sector, and persistent mydriasis of the pupil, with no reaction to light and no near reflex. Follow-up of 3 years in one of the patients showed no change of symptoms. Only in one patient, with a history of anterior uveitis, an anterior chamber tap was positive for herpes simplex genome. Only after the use of moxifloxacin did she experience continuous photophobia. CONCLUSIONS: Iris transillumination and sphincter paralysis is a newly recognized adverse effect of oral moxifloxacin therapy.},
  author       = {Wefers Bettink-Remeijer, Marijke and Brouwers, Katrien and Van Langenhove, Luc and De Waard, Peter and Missotten, Tom and Martinez Ciriano, Jos{\'e} and Van Aken, Elisabeth},
  issn         = {0950-222X},
  journal      = {Eye},
  language     = {eng},
  number       = {12},
  pages        = {2260--2262},
  title        = {Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin},
  url          = {http://dx.doi.org/10.1038/eye.2009.234},
  volume       = {23},
  year         = {2009},
}

Altmetric
View in Altmetric
Web of Science
Times cited: